Menu
Sign In Search Podcasts Charts People & Topics Add Podcast API Pricing
Podcast Image

Dear Menopause

113: Hot Take with Sonya and Johanna

20 Mar 2025

Description

Updates on the rapidly changing landscape of menopause care in Australia and globally, focusing on revolutionary PBS changes making hormone therapy more affordable and the growing momentum around women's health initiatives.• Pharmaceutical Benefits Scheme (PBS) now includes Estrogel, Prometrium, and Estrogel Pro (as of March 1st), with Slinder joining May 1st• PBS prescriptions require specific coding - you may need a new prescription to access subsidised pricing• FDA removed warnings from testosterone in the USA, highlighting the need for Australia to update outdated warnings on vaginal estrogen products• The "So Hot Right Now" Medical Conference created an inclusive learning environment for healthcare providers to discuss menopause care• Government funding for GP education ($1.5 million) lacks sufficient scope and evaluation mechanisms• Dr. Lisa Mosconi leading a $50 million research program to reduce Alzheimer's in women by studying the relationship between protective hormones and brain health• Jo launches Sheela Consulting - Unapologetic Advocacy, focusing on women's health policy and advocacyIf you've missed any of our expert conversations over the past two years, go back and listen, and please share them with anyone who needs this information.To listen to my previous episode and interview with Assistant Minister Ged Kearney, please head to episode 110.Links:Johanna Wicks - LinkedInSo Hot Right Now Medical ConferenceDr Lisa Mosconi - CARE fundingAustralian Government $573M fundingThank you for listening to my show! Join the conversation on Instagram

Audio
Featured in this Episode

No persons identified in this episode.

Transcription

This episode hasn't been transcribed yet

Help us prioritize this episode for transcription by upvoting it.

0 upvotes
🗳️ Sign in to Upvote

Popular episodes get transcribed faster

Comments

There are no comments yet.

Please log in to write the first comment.